Investor Anxiety Continues to Run High
September 09, 2020 at 08:28 AM EDT
News that the AstraZeneca Phase 3 test had to be stopped to study the adverse reaction of one subject added to the uncertainty of investors amid one of the more significant reversals of risk appetites since March.